» Articles » PMID: 24037242

Network-based Stratification of Tumor Mutations

Overview
Journal Nat Methods
Date 2013 Sep 17
PMID 24037242
Citations 404
Authors
Affiliations
Soon will be listed here.
Abstract

Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tumor genome sequences provide a rich new source of data for uncovering these subtypes but have proven difficult to compare, as two tumors rarely share the same mutations. Here we introduce network-based stratification (NBS), a method to integrate somatic tumor genomes with gene networks. This approach allows for stratification of cancer into informative subtypes by clustering together patients with mutations in similar network regions. We demonstrate NBS in ovarian, uterine and lung cancer cohorts from The Cancer Genome Atlas. For each tissue, NBS identifies subtypes that are predictive of clinical outcomes such as patient survival, response to therapy or tumor histology. We identify network regions characteristic of each subtype and show how mutation-derived subtypes can be used to train an mRNA expression signature, which provides similar information in the absence of DNA sequence.

Citing Articles

Enhancing Molecular Network-Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities.

Zhang H, Lin C, Chen Y, Shen X, Wang R, Chen Y J Cell Mol Med. 2025; 29(1):e70351.

PMID: 39804102 PMC: 11726689. DOI: 10.1111/jcmm.70351.


Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A α for targeted cancer therapy.

Ashcroft F, Bourboula A, Mahammad N, Barbayianni E, Feuerherm A, Nguyen T Nat Commun. 2025; 16(1):164.

PMID: 39747052 PMC: 11696576. DOI: 10.1038/s41467-024-55536-9.


DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways.

Cai Z, Poulos R, Aref A, Robinson P, Reddel R, Zhong Q Cancer Res Commun. 2024; 4(12):3151-3164.

PMID: 39530738 PMC: 11652962. DOI: 10.1158/2767-9764.CRC-24-0285.


Network dynamics-based subtyping of Alzheimer's disease with microglial genetic risk factors.

Choi J, Lee J, Kang U, Chang H, Cho K Alzheimers Res Ther. 2024; 16(1):229.

PMID: 39415193 PMC: 11481771. DOI: 10.1186/s13195-024-01583-9.


Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations.

Dong X, Zhang D, Zhang X, Liu Y, Liu Y NPJ Syst Biol Appl. 2024; 10(1):114.

PMID: 39362887 PMC: 11449910. DOI: 10.1038/s41540-024-00445-2.


References
1.
Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

2.
Vaske C, Benz S, Sanborn J, Earl D, Szeto C, Zhu J . Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010; 26(12):i237-45. PMC: 2881367. DOI: 10.1093/bioinformatics/btq182. View

3.
Stamatoyannopoulos J, Adzhubei I, Thurman R, Kryukov G, Mirkin S, Sunyaev S . Human mutation rate associated with DNA replication timing. Nat Genet. 2009; 41(4):393-5. PMC: 2914101. DOI: 10.1038/ng.363. View

4.
Schaefer C, Anthony K, Krupa S, Buchoff J, Day M, Hannay T . PID: the Pathway Interaction Database. Nucleic Acids Res. 2008; 37(Database issue):D674-9. PMC: 2686461. DOI: 10.1093/nar/gkn653. View

5.
Chuang H, Lee E, Liu Y, Lee D, Ideker T . Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007; 3:140. PMC: 2063581. DOI: 10.1038/msb4100180. View